Viroclinics-DDL rebrands to Cerba Research

Viroclinics-DDL (referred to herein as Cerba Research, the Netherlands) a world leading vaccine and antiviral specialty laboratory providing research and clinical trial solutions rooted in virology, proudly announces changing its name to Cerba Research as of the 1st of April 2024.

Study uncovers how transposons use telomeres for survival in bacteria

Transposons, or “jumping genes” – DNA segments that can move from one part of the genome to another – are key to bacterial evolution and

March 7, 2025

SNAP emergency allotments: Reducing food insecurity in children

Study found that emergency SNAP allotments were associated with a decreased risk of food hardship in households with children, particularly among White and Hispanic families,

August 25, 2024

Study provides valuable insights into the DCB-only strategy for left main coronary artery disease

Sanna Uskela et al., at North Karelia Central Hospital-Heart Center, Finland, conducted a retrospective single-center registry study that focused on the use of drug-coated balloon

April 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.